Your browser is no longer supported. Please, upgrade your browser.
Settings
INSY INSYS Therapeutics, Inc. daily Stock Chart
INSY [NASD]
INSYS Therapeutics, Inc.
Index- P/E107.79 EPS (ttm)0.10 Insider Own0.10% Shs Outstand72.19M Perf Week7.48%
Market Cap809.25M Forward P/E43.45 EPS next Y0.26 Insider Trans16.08% Shs Float23.17M Perf Month1.17%
Income7.60M PEG3.85 EPS next Q-0.10 Inst Own37.50% Short Float46.83% Perf Quarter13.81%
Sales242.30M P/S3.34 EPS this Y-86.60% Inst Trans-13.75% Short Ratio11.68 Perf Half Y-0.71%
Book/sh3.69 P/B3.04 EPS next Y176.50% ROA4.60% Target Price16.80 Perf Year-27.21%
Cash/sh2.53 P/C4.43 EPS next 5Y28.00% ROE6.10% 52W Range8.70 - 19.96 Perf YTD21.85%
Dividend- P/FCF16.75 EPS past 5Y16.50% ROI2.40% 52W High-43.82% Beta0.67
Dividend %- Quick Ratio2.70 Sales past 5Y- Gross Margin89.50% 52W Low28.87% ATR0.53
Employees423 Current Ratio2.90 Sales Q/Q-39.50% Oper. Margin6.60% RSI (14)54.68 Volatility3.90% 5.06%
OptionableYes Debt/Eq0.00 EPS Q/Q-122.60% Profit Margin6.60% Rel Volume1.43 Prev Close11.21
ShortableYes LT Debt/Eq0.00 EarningsApr 27 BMO Payout0.00% Avg Volume928.95K Price11.21
Recom1.80 SMA205.46% SMA502.22% SMA200-7.97% Volume280,643 Change0.02%
Dec-21-16Reiterated RBC Capital Mkts Outperform $23 → $16
Sep-22-16Reiterated RBC Capital Mkts Outperform $32 → $26
Apr-12-16Reiterated Jefferies Buy $23 → $17
Apr-11-16Reiterated Piper Jaffray Overweight $46 → $28
Feb-24-16Reiterated Jefferies Buy $36 → $23
Feb-01-16Reiterated RBC Capital Mkts Outperform $49 → $44
Mar-09-15Reiterated RBC Capital Mkts Outperform $65 → $71
Mar-04-15Reiterated RBC Capital Mkts Outperform $57 → $65
Dec-15-14Reiterated RBC Capital Mkts Outperform $53 → $57
Nov-12-14Reiterated RBC Capital Mkts Outperform $51 → $53
Nov-12-14Downgrade Oppenheimer Outperform → Perform $40
Oct-02-14Initiated RBC Capital Mkts Outperform $51
Aug-14-13Reiterated Oppenheimer Outperform $23 → $27
Jul-31-13Initiated Oppenheimer Outperform $23
Apr-27-17 08:34AM  INSYS Therapeutics, Inc. breached its 50 day moving average in a Bullish Manner : INSY-US : April 27, 2017 Capital Cube
Apr-26-17 12:11PM  INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders It Has Filed in U.S. District Court to Recover Losses Suffered by Investors in INSYS Therapeutics, Inc. GlobeNewswire +6.66%
10:30AM  The Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Insys Therapeutics, Inc. Investors and Encourages Investors to Contact the Firm Business Wire
Apr-25-17 04:30PM  Insys Therapeutics to Report First Quarter 2017 Results on May 9, 2017 GlobeNewswire
Apr-24-17 04:37PM  EQUITY ALERT: Levi & Korsinsky, LLP Reminds Shareholders It Has Filed in U.S. District Court to Recover Losses Suffered by Investors in INSYS Therapeutics, Inc. Accesswire
07:00AM  Dr. Steven James Joins Insys Therapeutics as Vice President of Medical Affairs GlobeNewswire
Apr-21-17 11:08AM  Better Know a Marijuana Stock: Insys Therapeutics Motley Fool
10:20AM  SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against INSYS Therapeutics, Inc. (INSY) and Lead Plaintiff Deadline: May 16, 2017 Accesswire
Apr-20-17 02:20PM  ETFs with exposure to INSYS Therapeutics, Inc. : April 20, 2017 Capital Cube
Apr-19-17 04:32PM  INSY EQUITY ALERT: The Law Offices of Vincent Wong Reminds Investors of INSYS Therapeutics, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of May 16, 2017 - INSY Accesswire
Apr-14-17 06:15PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in INSYS Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline - INSY Accesswire
Apr-13-17 03:40PM  INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders It Has Filed in U.S. District Court to Recover Losses Suffered by Investors in INSYS Therapeutics, Inc. Business Wire
10:19AM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against INSYS Therapeutics, Inc. (INSY) and Lead Plaintiff Deadline: May 16, 2017 Accesswire
07:54AM  One company symbolizes everything sickening about the opioid crisis Business Insider
Apr-11-17 09:30AM  Biotech Movers Trading Positive Ahead of Market's Open TheStreet.com
08:15AM  INSYS Therapeutics, Inc. breached its 50 day moving average in a Bullish Manner : INSY-US : April 11, 2017 Capital Cube
Apr-10-17 11:38AM  The Klein Law Firm Announces the Filing of a Class Action on Behalf of INSYS Therapeutics, Inc. Shareholders and a Lead Plaintiff Deadline of May 16, 2017 Accesswire +6.47%
08:25AM  5 Drug-Developing Marijuana Stocks You Need to Know Motley Fool
Apr-07-17 08:07PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in INSYS Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline - INSY Accesswire
04:53PM  ETFs with exposure to INSYS Therapeutics, Inc. : April 7, 2017 Capital Cube
Apr-06-17 03:57PM  The Klein Law Firm Announces a Class Action Filed on Behalf of INSYS Therapeutics, Inc. Shareholders and a Lead Plaintiff Deadline of May 16, 2017 GlobeNewswire
01:28PM  EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Insys Therapeutics, Inc. INSY GlobeNewswire
10:10AM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against INSYS Therapeutics, Inc. (INSY) & Lead Plaintiff Deadline: May 16, 2017 GlobeNewswire
Apr-05-17 05:00PM  DepoMed, Opioid Makers Fall After Trump's FDA Pick Says America's Drug Addiction Is Out of Control TheStreet.com
12:34PM  INSYS Therapeutics, Inc. :INSY-US: Earnings Analysis: Q4, 2016 By the Numbers : April 5, 2017 Capital Cube
11:24AM  A new market high: First marijuana stock index ETF launches CNBC
09:59AM  INSYS Therapeutics, Inc. :INSY-US: Earnings Analysis: 2016 By the Numbers : April 5, 2017
Apr-04-17 02:10PM  INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders it Has Filed to Recover Losses Suffered by Investors in INSYS Therapeutics, Inc. and Set a Lead Plaintiff Deadline of May 16, 2017 -- INSY Accesswire -6.23%
01:48PM  Glancy Prongay & Murray Announces the Filing of a Securities Class Action on Behalf of Insys Therapeutics, Inc. Investors and Encourages Investors to Contact the Firm Business Wire
11:00AM  Why This Marijuana Stock Fell 16.4% in March Motley Fool
10:31AM  Play the Marijuana Rush as First Marijuana-Focused ETF Launches Zacks
Apr-03-17 03:23PM  INSYS THERAPEUTICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and
03:07PM  INVESTOR ALERT: Brower Piven Encourages Shareholders Who Have Losses In Excess Of $100,000 From Investment In INSYS Therapeutics, Inc. To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit Business Wire
12:45PM  INSY INVESTOR ALERT: The Law Offices of Vincent Wong Notifies Investors of INSYS Therapeutics, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of May 16, 2017 - INSY Accesswire
07:52AM  Insys' revenue plunges as Subsys prescriptions fall Reuters
07:30AM  Insys Therapeutics reports 4Q loss
07:11AM  Insys Therapeutics' revenue falls 41.6 pct
07:01AM  INSYS THERAPEUTICS, INC. Files SEC form 10-K, Annual Report
06:50AM  Insys Therapeutics Reports Fourth Quarter and Year End 2016 Results GlobeNewswire
Mar-31-17 08:58PM  Insys to restate some financial statements
06:58PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in INSYS Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline INSY GlobeNewswire
05:12PM  INSYS THERAPEUTICS, INC. Files SEC form 8-K, Non-Reliance on Previous Financials, Audits or Interim Review, Regulatio
Mar-29-17 04:19PM  Will This Biotech Survive Activist Investor Or Get Taken Over?
12:02PM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders It Has Filed in U.S. District Court to Recover Losses Suffered by Investors in INSYS Therapeutics, Inc. -- Sets Lead Plaintiff Deadline of May 16, 2017 -- INSY Accesswire
10:18AM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against INSYS Therapeutics, Inc. (INSY) and Lead Plaintiff Deadline: May 16, 2017 Accesswire
09:30AM  Depomed Board of Directors Shaken Up While Insys Therapeutics Appoints a New CEO Accesswire
Mar-28-17 04:52PM  [$$] Senator McCaskill Begins Probe of Prescription Opioid Marketing at The Wall Street Journal
04:43PM  INSY SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notifies Investors of INSYS Therapeutics, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of May 16, 2017 INSY GlobeNewswire
12:49PM  U.S. senator launches probe into five top opioid drugmakers Reuters
08:08AM  INSYS Therapeutics, Inc. breached its 50 day moving average in a Bullish Manner : INSY-US : March 28, 2017
Mar-27-17 03:46PM  INSYS THERAPEUTICS, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhi
07:00AM  Insys Announces Saeed Motahari to Become President and Chief Executive Officer and Member of the Board of Directors Effective April 17, 2017 GlobeNewswire
Mar-26-17 08:30AM  Marijuana News Roundup: Feds Sentenced 3,500 to Prison Last Year for Pot-Related Offenses
Mar-24-17 05:27PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in INSYS Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline - INSY PR Newswire
05:15PM  Pawar Law Group Announces Filing of Securities Class Action Lawsuit Against Insys Therapeutics, Inc. - INSY Accesswire
04:20PM  A New Marijuana Medicine Gets DEA Scheduling, but It's Not All Good News at Motley Fool
03:20PM  INSY NOTICE: Rosen Law Firm Reminds Insys Therapeutics, Inc. Investors of Important Deadline Class Action Business Wire
01:46PM  INVESTOR ALERT: Law Offices of Howard G. Smith Commences Investigation on Behalf of Insys Therapeutics, Inc. Investors Business Wire
01:18PM  SHAREHOLDER ALERT: Brower Piven Notifies Investors of Class Action Lawsuit And Encourages Those Who Have Losses In Excess Of $100,000 From Investment In INSYS Therapeutics, Inc. (INSY) To Contact Brower Piven Before The Lead Plaintiff Deadl GlobeNewswire
09:30AM  Zacks Industry Outlook Highlights: Varian Medical Systems, T2 Biosystems, Edwards Lifesciences, INSYS Therapeutics and Cerner
08:21AM  Why Wasn't Insys Therapeutics' Bounce Bigger? at Motley Fool
Mar-23-17 07:35PM  Robbins Arroyo LLP: Insys Therapeutics, Inc. (INSY) Misled Shareholders According to a Recently Filed Class Action Business Wire
11:24AM  Insys Therapeutics' Syndros Gets Final DEA Rule at Investopedia
09:36AM  Biotech Premarket Movers: Insys, Ultragenyx, Alexion
07:34AM  DEA Schedules Insys Therapeutics Syndros (dronabinol oral solution) as Schedule II Drug GlobeNewswire
Mar-21-17 10:10AM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against INSYS Therapeutics, Inc. (INSY) & Lead Plaintiff Deadline: May 16, 2017 GlobeNewswire
07:22AM  Is This the Best Marijuana Stock to Buy Right Now? at Motley Fool
Mar-20-17 12:57PM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of INSYS Therapeutics, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of May 16, 2017 INSY GlobeNewswire
Mar-18-17 12:26PM  Companies Aiming for the Billion-Dollar Opioid Addiction Market
Mar-17-17 05:07PM  EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Insys Therapeutics, Inc. INSY Business Wire
02:27PM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against INSYS Therapeutics, Inc. (INSY) & Lead Plaintiff Deadline: May 16, 2017 PR Newswire
11:37AM  Pomerantz Law Firm Announces the Filing of a Class Action against INSYS Therapeutics, Inc. and Certain Officers INSY GlobeNewswire
Mar-16-17 06:52PM  EQUITY ALERT: Rosen Law Firm Announces Investigation of Securities Claims Against Insys Therapeutics, Inc. - INSY Business Wire
04:52PM  IMPORTANT INVESTOR ALERT: Goldberg Law PC Announces an Investigation of Insys Therapeutics, and Advises Investors with Losses to Contact the Firm Business Wire
03:00PM  Insys Falls on Earnings Delay
02:12PM  Glancy Prongay & Murray LLP Commences Investigation on Behalf of Insys Therapeutics, Inc. Investors Business Wire
01:58PM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces the Commencement of an Investigation Involving Possible Securities Fraud Violations by Certain Officers and Directors of INSYS Therapeutics, Inc. Business Wire
01:58PM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of INSYS Therapeutics, Inc. (INSY) PR Newswire
12:09PM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of INSYS Therapeutics, Inc - INSY PR Newswire
08:06AM  INSYS Therapeutics, Inc. breached its 50 day moving average in a Bearish Manner : INSY-US : March 16, 2017
Mar-15-17 04:36PM  INSYS THERAPEUTICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and
04:30PM  Insys Therapeutics Announces Delay in the Release of its Fourth Quarter and Full Year 2016 Results GlobeNewswire
Mar-14-17 02:05PM  5 Earnings Short-Squeeze Plays: Tiffany, Athene and More
Mar-04-17 11:40AM  About to Buy Marijuana Stocks? Read This First at Motley Fool
Mar-02-17 03:42PM  What Caused This Marijuana Stock to Soar 27% in February? at Motley Fool
09:18AM  Insys Therapeutics to Report Fourth Quarter and Full Year 2016 Results GlobeNewswire
Feb-24-17 02:56PM  2 doctors face up to 20 years in prison for running a $40 million opioid 'pill mill' -6.02%
10:22AM  [$$] Alabama Doctors Convicted in Health-Care Fraud Case at The Wall Street Journal
07:49AM  INSYS Therapeutics (INSY) is in Overbought Territory: What's Next?
Feb-23-17 09:39AM  [2/23] This Weeks Earnings Revisions Movers -5.04%
Feb-22-17 03:52PM  Drug Addiction Treatment Stocks to Watch +6.56%
08:43AM  Are Options Traders Betting on a Big Move in Insys Therapeutics (INSY) Stock?
Feb-19-17 09:18AM  Marijuana Stocks: Plenty of Business Diversity, Yet One Common Theme at Motley Fool
Feb-17-17 05:40PM  Here's Why This Marijuana Stock Jumped 15% This Week at Motley Fool
Feb-16-17 04:51PM  INSYS Therapeutics, Inc.: Sudden move in price, will it continue?
09:30AM  Biotech Industry Shaping up to Have a Breakout Year in 2017: Today's Reports on Insys Therapeutics and Zosano Pharma Accesswire
Feb-15-17 09:41AM  Gurus' Worst Recent Investments +12.24%
07:00AM  Insys Therapeutics Announces Use of Cannabidiol Oral Solution for Compassionate Use Studies in Patients Completing Long-Term Safety Study GlobeNewswire
Feb-14-17 04:30PM  Insys Therapeutics, Inc. to Present at 2017 RBC Capital Markets Global Healthcare Conference GlobeNewswire
Feb-08-17 02:19PM  INSYS Therapeutics, Inc. Value Analysis (NASDAQ:INSY) : February 8, 2017
Insys Therapeutics, Inc., a specialty pharmaceutical company, develops and commercializes supportive care products. The company markets SUBSYS, a sublingual fentanyl spray for breakthrough cancer pain in opioid-tolerant cancer patients in the United States. Its lead product candidate is SYNDROS, an orally administered liquid formulation of dronabinol for treating CINV and anorexia associated with weight loss in patients with AIDS. The company is also developing Cannabidiol Oral Solution, a synthetic cannabidiol for childhood catastrophic epilepsy syndromes; and other product candidates, including other dronabinol line extensions and sublingual spray product candidates. Insys Therapeutics, Inc. is headquartered in Chandler, Arizona.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
MEYER STEVEN JDirectorNov 04Buy10.7510,000107,48944,083Nov 07 10:14 AM
MEYER STEVEN JDirectorSep 01Option Exercise13.575006,78534,083Sep 01 04:23 PM
STANLEY THEODORE HDirectorAug 16Option Exercise5.9615,00089,40017,000Aug 16 08:23 PM
STANLEY THEODORE HDirectorAug 16Sale18.0215,000270,3002,000Aug 16 08:23 PM
JOHN N KAPOOR TRUST DATED SEPT10% OwnerAug 12Buy18.575,700105,85342,430,310Aug 12 03:40 PM
FOURTEAU PATRICKDirectorAug 11Sale18.4615,000276,90049,682Aug 12 04:51 PM
BRENNAN DANIELExec VP & Chf Operations Off.Aug 09Sale19.165,781110,7521Aug 09 07:12 PM
MEYER STEVEN JDirectorAug 04Option Exercise14.081,19416,80633,583Aug 04 06:49 PM
MEYER STEVEN JDirectorJul 06Option Exercise14.4469510,03632,389Jul 06 04:12 PM
MEYER STEVEN JDirectorJun 07Option Exercise14.081,19416,80631,694Jun 07 09:33 PM
BAKER DARRYL SChief Financial OfficerMay 23Option Exercise13.5710,000135,70021,030May 23 04:40 PM
MEYER STEVEN JDirectorMay 18Option Exercise13.575006,78530,500May 18 04:39 PM
JOHN N KAPOOR TRUST DATED SEPT10% OwnerMay 12Buy12.4110,000124,11942,424,610May 12 07:06 PM
JOHN N KAPOOR TRUST DATED SEPT10% OwnerMay 11Buy12.9440,000517,70842,414,610May 12 07:06 PM